Introduction This report analyses Peak XV Partners’ (formerly Sequoia India & SEA) investments in Indian unlisted companies that went on to list between 2020 and 2025. It tracks each portfolio company’s journey from first institutional investment to IPO, focusing on capital deployed, exits achieved, and return multiples measured up to the IPO date. About the…
Read more
A Deep Dive Into Value Unlock, Investor Journeys & Market Timing The NephroPlus IPO has arrived with remarkable buzz. And understandably so. After all, this isn’t merely another healthcare listing; rather, it’s the culmination of a decade-long journey powered by patient capital, strategic partnerships, and consistent scale-up. Moreover, the Offer for Sale (OFS) attached to…
Read more
As Aequs heads to the public markets, investors are naturally asking: who’s actually liquidating in this IPO? While the allotment size and valuation chatter dominate headlines, the seller list itself reveals a story of early conviction, strategic capital, and timely exits. Before diving into the shareholder breakdown, remember:Total Value of Investment = Current Value of…
Read more
In India’s vibrant capital market, a few investors stand out not just for spotting potential but for timing it right. Niveshaay has quietly built a reputation for identifying growth stories before they hit the public market. Its Pre-IPO investments reveal how conviction, patience, and timing blend to generate sustainable returns. Between 2020 and 2025, Niveshaay…
Read more